The largest database of trusted experimental protocols

7 protocols using tta a2

1

Perfusion of Tissues with Oxygenated KRB Solution

Check if the same lab product or an alternative is used in the 5 most similar protocols
All tissues were perfused continuously with KRB solution containing (mmol/L): NaCl, 5.9; NaHCO3, 120.35; KCl, 1.2; MgCl2, 15.5; NaH2PO4,1.2; CaCl2, 2.5; and glucose, 11.5. The KRB solution was warmed to a physiological temperature of 37 ± 0.3°C and bubbled with a mixture of 97% O2 – 3% CO2. For experiments utilizing external solutions with 0 [Ca2+]o, CaCl2 was omitted and 0.5 mM ethylene glycol-bis (β-aminoethyl ether)-N, N, N’, N’–tetraacetic acid (EGTA) was added to the solution. NNC 55–0396 and TTA-A2 were purchased from Alomone Labs (Jerusalem, Israel). 2-aminoethyl-diphenylborinate (2-APB), tetracaine, nicardipine, pinacidil was purchased from Millipore-Sigma (St. Louis, Missouri, USA). Thapsigargin, isradipine, Z-944, CPA and ryanodine were purchased from Tocris Bioscience (Ellisville, Missouri, USA). GSK 7975A was purchased from Aobious (Aobious INC, MA, USA), and xestospongin C (XeC) was purchased from Cayman Chemical (Michigan, USA).
+ Open protocol
+ Expand
2

In Vitro and In Vivo Drug Preparation

Check if the same lab product or an alternative is used in the 5 most similar protocols
TTA-A2 and TTX were purchased from Alomone Labs and Tocris Bioscience (Bristol, UK), respectively; other chemicals were from Sigma-Aldrich. All drugs were dissolved in distilled water for in vitro experiments or in saline for in vivo experiments, except for TTA-A2, which was dissolved in dimethyl sulfoxide at high times first and then diluted to the final concentration in saline.
+ Open protocol
+ Expand
3

Voltage Clamp Analysis of Ion Currents

Check if the same lab product or an alternative is used in the 5 most similar protocols
Voltage clamp experiments to define steady-state Kv7 current, persistent sodium current, and T-type calcium current used slow (20 mV/s) ramps from −95 to +5 mV. Voltage clamp experiments to define steady-state HCN current used ramps from −105 to −55 mV (20 mV/s), delivered after a 2- second holding period at −105 mV to activate HCN channels. We isolated the Kv7 potassium current by subtracting the whole current before and after bath application of 10–20 μM XE-991 (Abcam), sodium current by subtraction using 1 μM tetrodotoxin (TTX, Abcam), T-type calcium current by subtraction using 2 μM TTA-A2 (Alomone), and HCN current by subtraction using 100 μM ZD-7288 (Tocris). 10 μM retigabine (Alomone) was applied to enhance Kv7 potassium current. In experiments comparing local application of ZD-7288 to the soma versus bath application to the entire cell, we used 1 mM ZD-7288 in the puffer pipette to ensure that the lesser effect of somatic application was not due to failure to saturate block of somatic HCN channels.
+ Open protocol
+ Expand
4

Perfused Tissue Maintenance Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
All tissues were perfused and maintained with KRB solution containing (mmol/liter): 120.35 NaCl, 15.5 NaHCO3, 5.9 KCl, 1.2 MgCl2, 1.2 NaH2PO4, 2.5 CaCl2, and 11.5 glucose. The KRB solution warmed to a physiological temperature of 37 ± 0.2°C and bubbled with a mixture of 97% O2–3% CO2. For experiments using external solutions with zero [Ca2+]o, CaCl2 was omitted and 1 mM EGTA was added to the solution. NNC 55-0396 and TTA-A2 were purchased from Alomone Labs, nicardipine was purchased from Sigma-Aldrich, thapsigargin, isradipine, and ryanodine were purchased from Tocris Bioscience, and multiple batches of Xestospongin C (XeC) were purchased from Cayman Chemical.
+ Open protocol
+ Expand
5

Evaluation of Monoamine Release by SAK3

Check if the same lab product or an alternative is used in the 5 most similar protocols
SAK3 was synthesized by Shiratori pharmaceutical Ltd (Chiba, Japan; Fig 1A) according to a previous study [18 (link)]. As SAK3 (0.5 mg/kg, p.o.) shows maximal effects of ACh release and significant cognitive enhancement in several animal models including APPNL-F KI mice [18 (link),19 (link),22 ], we chose dose of SAK3 at 0.5 mg/kg to evaluate monoamine release. SAK3 was dissolved in distilled water. T-type calcium channel inhibitor, NNC 55–0396 (1 μM: Sigma-Aldrich, St-Louis, MO) [23 (link)], TTA-A2 (1 μM: Alomone Labs, Jerusalem, Israel), α7 nAChR antagonist MLA (1 nM: Sigma-Aldrich), and α4β2 nAChR antagonist DhβE (100 μM: Tocris, Bristol, UK) were dissolved in Ringer’s solution.
+ Open protocol
+ Expand
6

Pressure Myography of Lymphatic Vessels

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lymphatic vessels were isolated and cannulated in 0.5% albumin-supplemented Krebs buffer; the cannulating pipettes contained the same solution. Pressure myograph experiments were conducted in Krebs buffer without albumin. Krebs buffer contained (in mM): NaCl, 146.9; KCl, 4.7; CaCl2, 2; MgSO4, 1.2; NaH2PO4.H2O, 1.2; NaHCO3, 3; Na-HEPES, 1.5; D-glucose, 5 (pH 7.4, 37 °C). For patch clamp recordings, the physiological Ca2+ bath solution contained (in mM): 1.8 CaCl2, 110 NaCl, 1 CsCl, 1.2 MgCl2, 10 HEPES, 10 D-glucose (pH adjusted to 7.4 with NaOH). Ba2+ bath solution contained (in mM): 10 or 20 BaCl2, 110 NaCl, 1 CsCl, 1.2 MgCl2, 10 HEPES, 10 D-glucose (pH adjusted to 7.4 with NaOH). Patch pipettes contained (in mM): 135 CsCl, 10 HEPES, 10 EGTA, 5 GTP·Mg, (pH adjusted to 7.2 with CsOH). All chemicals were obtained from Sigma (St. Louis, MO, USA), except for BSA (US Biochemicals; Cleveland, OH, USA), MgSO4, HEPES (Fisher Scientific; Pittsburgh, PA, USA), and TTA-A2 (Alomone, Israel). TTA-A2, nifedipine and Bay K8644 were dissolved in DMSO. Ni2+, mibefradil and acetylcholine were dissolved in Krebs buffer (pre-warmed for Ni2+) without BSA. DMSO by itself, at its maximal concentration (0.033%) had no effect on contractions.
+ Open protocol
+ Expand
7

Electrophysiological Experiment Reagents

Check if the same lab product or an alternative is used in the 5 most similar protocols
TTA-A2 and TTA-P2 were obtained from Alomone Labs. Tetrodotoxin (TTX) was obtained from Tocris Bioscience (Bristol, UK). All the other drugs for electrophysiological experiment were obtained from Sigma-Aldrich (St. Louis, MO, USA). All chemicals were dissolved in distilled water except that TTA-A2 and TTA-P2 was dissolved in DMSO and were stored at −20°C unless otherwise mentioned.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!